首页 > 最新文献

Interventional Neuroradiology最新文献

英文 中文
DWI lesions after intracranial aneurysm treatment with contour or WEB-does the device matter? 使用轮廓仪或 WEB 治疗颅内动脉瘤后的 DWI 病变--设备是否重要?
IF 1.5 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-26 DOI: 10.1177/15910199241290844
Friederike Gärtner, Tristan Klintz, Sönke Peters, Justus Mahnke, Karim Mostafa, Fernando Bueno Neves, Johannes Hensler, Naomi Larsen, Olav Jansen, Fritz Wodarg

Objective: In this study, we report our experience with the occurrence of diffusion-weighted imaging (DWI) lesions following aneurysm treatment with Woven EndoBridge (WEB) device and Contour Neurovascular System in elective settings. We compared both techniques in a retrospective single-center analysis, to investigate whether there are significant differences in the incidence of microemboli depending on the device used.

Materials and methods: Sixty-two cases treated with Contour were retrospectively compared with 84 WEB cases. Postinterventional MRI was performed in all patients within five days after the angiographic procedure. Only DWI lesions in the dependent vascular territory of the treated aneurysm were considered. Data on occurrence of DWI lesions, device implantation times as well as device change or repositions maneuvers were compared.

Results: A total of 146 patients were included in this study. Postinterventional DWI lesions were detected in 33 of the 62 (53.2%) Contour cases and in 36 of the 84 (42.8%) WEB cases with an average lesion number of 1.70 ± 3.45 in our WEB group and 1.68 ± 2.53 in our Contour cohort. Neither periinterventional device changes nor device reposition maneuvers had a significant impact on the occurrence of DWI lesions. Although four patients experienced transient neurological deterioration, the DWI lesions were not clinically relevant at the time of discharge, as the patients' NIHSS remained stable compared to the preintervention NIHSS in the entire cohort. There was no statistically significant difference between the implantation times of WEB and Contour, although Contour could be implanted slightly faster.

Conclusion: Aneurysm treatment with WEB or Contour results in a comparable numbers of procedure-related DWI lesions. This effect was consistent after adjustment for other demographic or technical variables.

目的:在这项研究中,我们报告了在择期手术中使用 Woven EndoBridge(WEB)装置和 Contour 神经血管系统治疗动脉瘤后发生弥散加权成像(DWI)病变的经验。我们在一项回顾性单中心分析中比较了这两种技术,以研究微栓子的发生率是否因所使用的装置不同而存在显著差异:我们将 62 例使用 Contour 治疗的病例与 84 例 WEB 病例进行了回顾性比较。所有患者均在血管造影术后五天内进行了介入后核磁共振成像。只考虑治疗后动脉瘤依附血管区域内的 DWI 病变。比较了 DWI 病变发生率、设备植入时间以及设备更换或重新定位操作的数据:结果:本研究共纳入 146 例患者。62例Contour病例中有33例(53.2%)发现了介入后DWI病变,84例WEB病例中有36例(42.8%)发现了介入后DWI病变,WEB组平均病变数为(1.70 ± 3.45),Contour组平均病变数为(1.68 ± 2.53)。介入周围设备更换或设备重新定位操作对 DWI 病变的发生均无明显影响。虽然有四名患者出现了短暂的神经功能恶化,但出院时 DWI 病变与临床无关,因为患者的 NIHSS 与整个队列干预前的 NIHSS 相比保持稳定。WEB和Contour的植入时间在统计学上没有明显差异,但Contour的植入速度稍快:结论:使用WEB或Contour治疗动脉瘤时,与手术相关的DWI病变数量相当。结论:使用WEB或Contour治疗动脉瘤时,与手术相关的DWI病变数量相当,在调整了其他人口统计学或技术变量后,这种效果仍然一致。
{"title":"DWI lesions after intracranial aneurysm treatment with contour or WEB-does the device matter?","authors":"Friederike Gärtner, Tristan Klintz, Sönke Peters, Justus Mahnke, Karim Mostafa, Fernando Bueno Neves, Johannes Hensler, Naomi Larsen, Olav Jansen, Fritz Wodarg","doi":"10.1177/15910199241290844","DOIUrl":"10.1177/15910199241290844","url":null,"abstract":"<p><strong>Objective: </strong>In this study, we report our experience with the occurrence of diffusion-weighted imaging (DWI) lesions following aneurysm treatment with Woven EndoBridge (WEB) device and Contour Neurovascular System in elective settings. We compared both techniques in a retrospective single-center analysis, to investigate whether there are significant differences in the incidence of microemboli depending on the device used.</p><p><strong>Materials and methods: </strong>Sixty-two cases treated with Contour were retrospectively compared with 84 WEB cases. Postinterventional MRI was performed in all patients within five days after the angiographic procedure. Only DWI lesions in the dependent vascular territory of the treated aneurysm were considered. Data on occurrence of DWI lesions, device implantation times as well as device change or repositions maneuvers were compared.</p><p><strong>Results: </strong>A total of 146 patients were included in this study. Postinterventional DWI lesions were detected in 33 of the 62 (53.2%) Contour cases and in 36 of the 84 (42.8%) WEB cases with an average lesion number of 1.70 ± 3.45 in our WEB group and 1.68 ± 2.53 in our Contour cohort. Neither periinterventional device changes nor device reposition maneuvers had a significant impact on the occurrence of DWI lesions. Although four patients experienced transient neurological deterioration, the DWI lesions were not clinically relevant at the time of discharge, as the patients' NIHSS remained stable compared to the preintervention NIHSS in the entire cohort. There was no statistically significant difference between the implantation times of WEB and Contour, although Contour could be implanted slightly faster.</p><p><strong>Conclusion: </strong>Aneurysm treatment with WEB or Contour results in a comparable numbers of procedure-related DWI lesions. This effect was consistent after adjustment for other demographic or technical variables.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241290844"},"PeriodicalIF":1.5,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559872/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142511427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of selective neurocritical care admission costs following elective endovascular treatment of unruptured intracranial aneurysms. 未破裂颅内动脉瘤选择性血管内治疗后神经重症监护入院费用分析。
IF 1.5 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-10 DOI: 10.1177/15910199241288880
Steven G Roth, Seoiyoung Ahn, Campbell Liles, Lohit Velagapudi, Nishit Mummareddy, Yeji Ko, Austin M Hilvert, Michael T Froehler, Matthew R Fusco, Rohan V Chitale

Introduction: No consensus exists on the necessity of neurocritical care unit (NCU)-level care following unruptured intracranial aneurysm (UIA) treatment. We aim to identify patients requiring NCU-level care post-treatment and determine potential cost savings utilizing a selective NCU admission protocol.

Methods: A retrospective analysis of all UIA patients who underwent endovascular treatment at a single center from 2017-2022 was conducted. Data on demographics, preprocedural variables, radiographic features, procedural techniques, intra/postoperative events, and length of stay (LOS) were collected. Multivariable analysis was performed to identify patients requiring NCU-level care post-treatment. Cost analysis using hospital cost data (not charges/reimbursement) was performed using simulated step-down and floor protocols for patients without NCU indications following a hypothetical six-hour post-anesthesia care unit observation period.

Results: Of 209 patients, 179 were discharged within 24 h and 30 had prolonged LOS. In our analysis, intra- and postoperative events independently predicted prolonged LOS. In our subanalysis, 47 patients demonstrated NCU needs: 24 with intraoperative indications, 18 with postoperative indications, and five with both. Of the 23 with postoperative indications, 20 were identified within six hours, while three were identified within six to 24 h. The median variable cost per patient for the current NCU protocol was $31,505 (IQR, $26,331-$37,053) vs. stepdown protocol $29,514 (IQR, $24,746-$35,011;p = 0.061) vs. floor protocol $26,768 (IQR, $22,214-$34,107;p < 0.001). Total variable costs were $6,211,497 for the current NCU protocol vs. $5,921,912 for the step-down protocol (4.89% savings) and $5,509,052 for the floor protocol (12.75% savings).

Conclusion: Most patients requiring NCU-level care following UIA treatment were identified within a six-hour postoperative window. Thus, selective NCU admission for this cohort following a six-hour observation period may be a logical avenue for cost reduction. Our analysis demonstrated 5% and 13% savings for uncomplicated patients using step-down and floor admission protocols, respectively.

导言:对于未破裂颅内动脉瘤(UIA)治疗后是否需要神经重症监护病房(NCU)级别的护理,目前尚无共识。我们旨在确定治疗后需要 NCU 级护理的患者,并利用选择性 NCU 入院方案确定潜在的成本节约:我们对 2017-2022 年间在一个中心接受血管内治疗的所有 UIA 患者进行了回顾性分析。收集了有关人口统计学、术前变量、影像学特征、手术技术、术中/术后事件和住院时间(LOS)的数据。进行了多变量分析,以确定治疗后需要接受 NCU 级护理的患者。使用医院成本数据(非收费/报销)进行成本分析,在假设的六小时麻醉后护理病房观察期后,对无NCU指征的患者采用模拟降级和楼层方案:在 209 名患者中,179 人在 24 小时内出院,30 人的住院时间较长。在我们的分析中,术中和术后事件可独立预测延长的 LOS。在我们的子分析中,47 名患者需要接受 NCU 治疗:24 人有术中适应症,18 人有术后适应症,5 人同时有术中和术后适应症。在 23 位有术后适应症的患者中,20 位在 6 小时内被确定,3 位在 6 到 24 小时内被确定。现行NCU方案与降级方案相比,每名患者的可变成本中位数分别为31,505美元(IQR,26,331-37,053美元)和29,514美元(IQR,24,746-35,011美元;P = 0.061),与底层方案相比,每名患者的可变成本中位数分别为26,768美元(IQR,22,214-34,107美元;P 结论:大多数接受 UIA 治疗后需要接受 NCU 级护理的患者都是在术后六小时内发现的。因此,在六小时观察期后有选择性地将这部分患者送入 NCU 可能是降低成本的合理途径。我们的分析表明,采用降级入院和楼层入院方案,无并发症患者可分别节省 5% 和 13%的费用。
{"title":"Analysis of selective neurocritical care admission costs following elective endovascular treatment of unruptured intracranial aneurysms.","authors":"Steven G Roth, Seoiyoung Ahn, Campbell Liles, Lohit Velagapudi, Nishit Mummareddy, Yeji Ko, Austin M Hilvert, Michael T Froehler, Matthew R Fusco, Rohan V Chitale","doi":"10.1177/15910199241288880","DOIUrl":"10.1177/15910199241288880","url":null,"abstract":"<p><strong>Introduction: </strong>No consensus exists on the necessity of neurocritical care unit (NCU)-level care following unruptured intracranial aneurysm (UIA) treatment. We aim to identify patients requiring NCU-level care post-treatment and determine potential cost savings utilizing a selective NCU admission protocol.</p><p><strong>Methods: </strong>A retrospective analysis of all UIA patients who underwent endovascular treatment at a single center from 2017-2022 was conducted. Data on demographics, preprocedural variables, radiographic features, procedural techniques, intra/postoperative events, and length of stay (LOS) were collected. Multivariable analysis was performed to identify patients requiring NCU-level care post-treatment. Cost analysis using hospital cost data (not charges/reimbursement) was performed using simulated step-down and floor protocols for patients without NCU indications following a hypothetical six-hour post-anesthesia care unit observation period.</p><p><strong>Results: </strong>Of 209 patients, 179 were discharged within 24 h and 30 had prolonged LOS. In our analysis, intra- and postoperative events independently predicted prolonged LOS. In our subanalysis, 47 patients demonstrated NCU needs: 24 with intraoperative indications, 18 with postoperative indications, and five with both. Of the 23 with postoperative indications, 20 were identified within six hours, while three were identified within six to 24 h. The median variable cost per patient for the current NCU protocol was $31,505 (IQR, $26,331-$37,053) vs. stepdown protocol $29,514 (IQR, $24,746-$35,011;p = 0.061) vs. floor protocol $26,768 (IQR, $22,214-$34,107;p < 0.001). Total variable costs were $6,211,497 for the current NCU protocol vs. $5,921,912 for the step-down protocol (4.89% savings) and $5,509,052 for the floor protocol (12.75% savings).</p><p><strong>Conclusion: </strong>Most patients requiring NCU-level care following UIA treatment were identified within a six-hour postoperative window. Thus, selective NCU admission for this cohort following a six-hour observation period may be a logical avenue for cost reduction. Our analysis demonstrated 5% and 13% savings for uncomplicated patients using step-down and floor admission protocols, respectively.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241288880"},"PeriodicalIF":1.5,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559827/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recognition of dural to pial supply in high-grade dural arteriovenous fistula: A technical note. 高位硬膜动静脉瘘中硬膜向静脉供应的识别: 技术说明。
IF 1.5 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-08 DOI: 10.1177/15910199241272596
Shigeta Miyake, Tze Phei Kee, Ivan Radovanovic, Karel Terbrugge, Timo Krings, Eef Jacobus Hendriks

High-grade dural arteriovenous fistulas (DAVFs) are known to demonstrate classical dural supply and can demonstrate pre-existing dural supply and 'pure' arterial supply from pial branches. The latter two are examples of congenital versus acquired pial to dural shunting, respectively. We describe the recognition of dural to pial supply during combined transarterial and transvenous embolization of a high-grade DAVF with holocephalic venous reflux, stressing the importance of careful assessment of this condition with micro catheter injections.

众所周知,高级别硬膜动静脉瘘(DAVFs)可表现为典型的硬膜供应,也可表现为预先存在的硬膜供应和来自桡动脉分支的 "纯 "动脉供应。后两者分别是先天性和后天性髓腔至硬脑膜分流的例子。我们描述了在经动脉和经静脉联合栓塞治疗伴有全脑静脉回流的高级别 DAVF 时发现硬脊膜到髓腔供血的情况,强调了通过微导管注射仔细评估这种情况的重要性。
{"title":"Recognition of dural to pial supply in high-grade dural arteriovenous fistula: A technical note.","authors":"Shigeta Miyake, Tze Phei Kee, Ivan Radovanovic, Karel Terbrugge, Timo Krings, Eef Jacobus Hendriks","doi":"10.1177/15910199241272596","DOIUrl":"10.1177/15910199241272596","url":null,"abstract":"<p><p>High-grade dural arteriovenous fistulas (DAVFs) are known to demonstrate classical dural supply and can demonstrate pre-existing dural supply and 'pure' arterial supply from pial branches. The latter two are examples of congenital versus acquired pial to dural shunting, respectively. We describe the recognition of dural to pial supply during combined transarterial and transvenous embolization of a high-grade DAVF with holocephalic venous reflux, stressing the importance of careful assessment of this condition with micro catheter injections.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241272596"},"PeriodicalIF":1.5,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559922/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance assessment of the Surpass Evolve flow diverter for the treatment of intracranial aneurysms: A systematic review and meta-analysis. Surpass Evolve 分流器治疗颅内动脉瘤的性能评估:系统回顾和荟萃分析。
IF 1.5 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-03 DOI: 10.1177/15910199241284412
Aaron Rodriguez-Calienes, Juan Vivanco-Suarez, Nicole M Castillo-Huerta, David Espinoza-Martinez, Cristian Morán-Mariños, Ximena Espiritu-Vilcapoma, Valeria Rivera-Angles, Santiago Ortega-Gutierrez

Background: The Surpass Evolve (SE) has emerged as a promising alternative treatment from the flow diverter series. The utilization of the SE has gradually increased, however, there is a scarcity of comprehensive data on the solidity of this technology in the endovascular treatment of intracranial aneurysms (IAs). This meta-analysis aimed to evaluate the safety and effectiveness of the SE flow diverter.

Methods: A systematic literature search from inception to April 2024 was conducted across five databases for studies involving IAs treated with the SE. The primary effectiveness outcome was the proportion of complete aneurysm occlusion at the final follow-up, and the primary safety outcome comprised a composite of early and delayed complications. Subgroup analyses based on aneurysm size, anatomical location, and rupture status were also conducted.

Results: Our analysis included nine studies with 645 patients and 722 IAs. Effectiveness outcomes revealed an overall complete aneurysm occlusion rate of 69% (95% confidence interval (CI) = 58%-78%; I2 = 72%) and a favorable aneurysm occlusion rate of 91% (95% CI = 82%-96%; I2 = 49%). Safety outcomes demonstrated an overall complications rate of 6% (95% CI = 3%-12%; I2 = 66%), with an early complications rate of 6% (95% CI = 4%-11%; I2 = 0%), and a delayed complications rate of 0% (95% CI = 0%-7%; I2 = 0%).

Conclusions: Our findings suggest a favorable outcome with a high rate of complete aneurysm occlusion at the last follow-up, with acceptable rates of neurological complications. Future research efforts should focus on larger, prospective studies with standardized outcome measures to further elucidate the clinical utility of the SE flow diverter in the management of IAs.

背景:Surpass Evolve(SE)已从血流分流器系列中脱颖而出,成为一种前景广阔的替代治疗方法。SE的使用率已逐渐提高,然而,关于该技术在颅内动脉瘤(IAs)血管内治疗中的稳固性,却缺乏全面的数据。这项荟萃分析旨在评估SE血流分流器的安全性和有效性:方法:在五个数据库中进行了从开始到2024年4月的系统性文献检索,以了解使用SE治疗颅内动脉瘤的研究情况。主要有效性结果是最终随访时动脉瘤完全闭塞的比例,主要安全性结果包括早期和延迟并发症的复合结果。我们还根据动脉瘤大小、解剖位置和破裂状况进行了分组分析:我们的分析包括九项研究,共涉及 645 名患者和 722 个动脉瘤。疗效结果显示,动脉瘤完全闭塞率为 69%(95% 置信区间 (CI) = 58%-78%;I2 = 72%),动脉瘤良好闭塞率为 91%(95% CI = 82%-96%;I2 = 49%)。安全结果显示,总体并发症发生率为 6% (95% CI = 3%-12%; I2 = 66%),早期并发症发生率为 6% (95% CI = 4%-11%; I2 = 0%),延迟并发症发生率为 0% (95% CI = 0%-7%; I2 = 0%):我们的研究结果表明,最后一次随访时动脉瘤完全闭塞率较高,神经系统并发症发生率尚可接受,结果良好。未来的研究工作应侧重于规模更大、采用标准化结果测量方法的前瞻性研究,以进一步阐明SE血流分流器在动脉瘤治疗中的临床效用。
{"title":"Performance assessment of the Surpass Evolve flow diverter for the treatment of intracranial aneurysms: A systematic review and meta-analysis.","authors":"Aaron Rodriguez-Calienes, Juan Vivanco-Suarez, Nicole M Castillo-Huerta, David Espinoza-Martinez, Cristian Morán-Mariños, Ximena Espiritu-Vilcapoma, Valeria Rivera-Angles, Santiago Ortega-Gutierrez","doi":"10.1177/15910199241284412","DOIUrl":"10.1177/15910199241284412","url":null,"abstract":"<p><strong>Background: </strong>The Surpass Evolve (SE) has emerged as a promising alternative treatment from the flow diverter series. The utilization of the SE has gradually increased, however, there is a scarcity of comprehensive data on the solidity of this technology in the endovascular treatment of intracranial aneurysms (IAs). This meta-analysis aimed to evaluate the safety and effectiveness of the SE flow diverter.</p><p><strong>Methods: </strong>A systematic literature search from inception to April 2024 was conducted across five databases for studies involving IAs treated with the SE. The primary effectiveness outcome was the proportion of complete aneurysm occlusion at the final follow-up, and the primary safety outcome comprised a composite of early and delayed complications. Subgroup analyses based on aneurysm size, anatomical location, and rupture status were also conducted.</p><p><strong>Results: </strong>Our analysis included nine studies with 645 patients and 722 IAs. Effectiveness outcomes revealed an overall complete aneurysm occlusion rate of 69% (95% confidence interval (CI) = 58%-78%; <i>I</i><sup>2 </sup>= 72%) and a favorable aneurysm occlusion rate of 91% (95% CI = 82%-96%; <i>I</i><sup>2 </sup>= 49%). Safety outcomes demonstrated an overall complications rate of 6% (95% CI = 3%-12%; <i>I</i><sup>2 </sup>= 66%), with an early complications rate of 6% (95% CI = 4%-11%; <i>I</i><sup>2 </sup>= 0%), and a delayed complications rate of 0% (95% CI = 0%-7%; <i>I</i><sup>2 </sup>= 0%).</p><p><strong>Conclusions: </strong>Our findings suggest a favorable outcome with a high rate of complete aneurysm occlusion at the last follow-up, with acceptable rates of neurological complications. Future research efforts should focus on larger, prospective studies with standardized outcome measures to further elucidate the clinical utility of the SE flow diverter in the management of IAs.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241284412"},"PeriodicalIF":1.5,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559873/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of sarcopenia on mortality in acute stroke patients receiving endovascular treatment. 肌肉疏松症对接受血管内治疗的急性中风患者死亡率的影响。
IF 1.5 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 Epub Date: 2024-01-17 DOI: 10.1177/15910199241227465
Muhammed Said Beşler, Nurdan Çay, Bige Sayın

Background: To investigate the effect of sarcopenia on mortality in patients with acute ischemic stroke caused by anterior circulation large artery occlusion who underwent endovascular treatment.

Methods: Acute ischemic stroke patients (n = 194) treated with mechanical thrombectomy who underwent chest computed tomography between 2019 and 2022 (median age, 69 [interquartile range: 61-77], 95 females, 99 males) were evaluated retrospectively. The cross-sectional area and density of the pectoralis muscle [pectoralis muscle area (PMA) and pectoralis muscle density (PMD)] at the level of the aortic arch and the erector spinae muscle at the T12 level [erector spinae muscle area (ESMA) and erector spinae muscle density (ESMD)] were measured. The association between skeletal muscle parameters and mortality outcomes was investigated using the receiver operating characteristic (ROC) curve and multivariable logistic regression analyses.

Results: The 90-day mortality rate was 32% in the study population (n = 62). The ROC analysis revealed that ESMD [area under the curve (AUC): 0.765] and PMD (AUC: 0.759) performed best in the prediction of 90-day mortality. In the multivariable logistic regression analysis, PMD [odds ratio (OR): 0.896; 95% confidence interval (CI): 0.846-0.948; p < 0.001], ESMA (OR: 0.929; 95% CI: 0.878-0.983; p = 0.011), and ESMD (OR: 0.947; 95% CI: 0.913-0.983; p = 0.004), but not PMA, were independent risk factors for 90-day mortality.

Conclusion: PMD, ESMA, and ESMD may be risk factors for 90-day mortality after mechanical thrombectomy for acute ischemic stroke.

背景:研究肌肉疏松症对接受血管内治疗的前循环大动脉闭塞所致急性缺血性脑卒中患者死亡率的影响:目的:研究肌肉疏松症对接受血管内治疗的前循环大动脉闭塞引起的急性缺血性卒中患者死亡率的影响:对2019年至2022年期间接受胸部计算机断层扫描的接受机械取栓术治疗的急性缺血性卒中患者(n = 194)(中位年龄69岁[四分位间范围:61-77],女性95人,男性99人)进行回顾性评估。研究人员测量了主动脉弓水平的胸肌横截面积和密度[胸肌面积(PMA)和胸肌密度(PMD)]以及T12水平的竖脊肌横截面积和密度[竖脊肌面积(ESMA)和竖脊肌密度(ESMD)]。采用接收器操作特征曲线(ROC)和多变量逻辑回归分析研究了骨骼肌参数与死亡率之间的关系:研究对象(n = 62)的 90 天死亡率为 32%。ROC分析显示,ESMD[曲线下面积(AUC):0.765]和PMD(AUC:0.759)在预测90天死亡率方面表现最佳。在多变量逻辑回归分析中,PMD[几率比(OR):0.896;95% 置信区间(CI):0.846-0.948;P = 0.011]和ESMD(OR:0.947;95% CI:0.913-0.983;P = 0.004)是90天死亡率的独立危险因素,而不是PMA:结论:PMD、ESMA 和 ESMD 可能是急性缺血性卒中机械取栓术后 90 天死亡率的风险因素。
{"title":"Effect of sarcopenia on mortality in acute stroke patients receiving endovascular treatment.","authors":"Muhammed Said Beşler, Nurdan Çay, Bige Sayın","doi":"10.1177/15910199241227465","DOIUrl":"10.1177/15910199241227465","url":null,"abstract":"<p><strong>Background: </strong>To investigate the effect of sarcopenia on mortality in patients with acute ischemic stroke caused by anterior circulation large artery occlusion who underwent endovascular treatment.</p><p><strong>Methods: </strong>Acute ischemic stroke patients (n = 194) treated with mechanical thrombectomy who underwent chest computed tomography between 2019 and 2022 (median age, 69 [interquartile range: 61-77], 95 females, 99 males) were evaluated retrospectively. The cross-sectional area and density of the pectoralis muscle [pectoralis muscle area (PMA) and pectoralis muscle density (PMD)] at the level of the aortic arch and the erector spinae muscle at the T12 level [erector spinae muscle area (ESMA) and erector spinae muscle density (ESMD)] were measured. The association between skeletal muscle parameters and mortality outcomes was investigated using the receiver operating characteristic (ROC) curve and multivariable logistic regression analyses.</p><p><strong>Results: </strong>The 90-day mortality rate was 32% in the study population (n = 62). The ROC analysis revealed that ESMD [area under the curve (AUC): 0.765] and PMD (AUC: 0.759) performed best in the prediction of 90-day mortality. In the multivariable logistic regression analysis, PMD [odds ratio (OR): 0.896; 95% confidence interval (CI): 0.846-0.948; <i>p</i> < 0.001], ESMA (OR: 0.929; 95% CI: 0.878-0.983; <i>p</i> = 0.011), and ESMD (OR: 0.947; 95% CI: 0.913-0.983; <i>p</i> = 0.004), but not PMA, were independent risk factors for 90-day mortality.</p><p><strong>Conclusion: </strong>PMD, ESMA, and ESMD may be risk factors for 90-day mortality after mechanical thrombectomy for acute ischemic stroke.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"728-737"},"PeriodicalIF":1.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569485/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139486634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WFITN 2024 - 17th Congress of World Federation of Interventional and Therapeutic Neuroradiology - October 6-10, 2024 - New York, USA. WFITN 2024 - 世界介入与治疗神经放射学联合会第 17 届大会 - 2024 年 10 月 6-10 日 - 美国纽约。
IF 1.5 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1177/15910199241285197
{"title":"WFITN 2024 - 17th Congress of World Federation of Interventional and Therapeutic Neuroradiology - October 6-10, 2024 - New York, USA.","authors":"","doi":"10.1177/15910199241285197","DOIUrl":"10.1177/15910199241285197","url":null,"abstract":"","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":"30 1_suppl","pages":"1-215"},"PeriodicalIF":1.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462984/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers to stroke treatment: The price of long-distance from thrombectomy centers. 中风治疗的障碍:远离血栓切除中心的代价。
IF 1.5 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-09-05 DOI: 10.1177/15910199241278036
Olav Søvik, Halvor Øygarden, Arnstein Tveiten, Martin Wilhelm Kurz, Kathinka Dæhli Kurz, Pål Johan Stokkeland, Hanne Brit Hetland, Hege Langli Ersdal, Per Kristian Hyldmo

Background: Endovascular thrombectomy, the preferred treatment for acute large-vessel occlusion stroke, is highly time-dependent. Many patients live far from thrombectomy centers due to large geographical variations in stroke services. This study aimed to explore the consequences of long transport distance on the proportion of thrombectomy-eligible patients who underwent thrombectomy, the clinical outcomes with or without thrombectomy, the timelines for patients transported, and the diagnostic accuracy of large-vessel occlusion in primary stroke centers.

Methods: We conducted a retrospective observational study in a county with only primary stroke centers, ∼ 300 km from the nearest thrombectomy center. All stroke patients admitted over a year were retrieved from the Norwegian Stroke Registry. A neuroradiologist identified all computed tomography images with large-vessel occlusions. A panel determined whether these patients had a corresponding clinical indication for thrombectomy.

Results: A total of 50% of the eligible patients did not receive thrombectomy. These patients had a significantly higher risk of severe disability or death compared to the patients who underwent thrombectomy. The median time from computed tomography imaging at the primary stroke center to arrival at the thrombectomy center was over 3 hours. Additionally, 30% of the large-vessel occlusions were initially undiagnosed, and half of these patients had a corresponding clinical indication for thrombectomy.

Conclusions: In a county with a long transport distance to a thrombectomy center, a high proportion of eligible patients did not undergo thrombectomy, negatively impacting clinical outcomes. The transport time was considerable. A high rate of large-vessel occlusions was initially not diagnosed.

背景:血管内血栓切除术是急性大血管闭塞性卒中的首选治疗方法,但其时间依赖性很强。由于卒中服务的地域差异很大,许多患者居住地离血栓切除中心很远。本研究旨在探讨长途运输对符合血栓切除术条件的患者接受血栓切除术的比例、接受或不接受血栓切除术的临床效果、患者转运的时间以及初级卒中中心对大血管闭塞的诊断准确性的影响:我们在一个只有初级卒中中心的县开展了一项回顾性观察研究,该县距离最近的血栓切除中心有 300 公里。我们从挪威卒中登记处检索了一年内收治的所有卒中患者。神经放射科医生对所有大血管闭塞的计算机断层扫描图像进行鉴定。一个专家小组确定这些患者是否有相应的血栓切除术临床指征:结果:共有50%的符合条件的患者没有接受血栓切除术。与接受血栓切除术的患者相比,这些患者严重残疾或死亡的风险明显更高。从初级卒中中心进行计算机断层扫描成像到到达血栓切除中心的中位时间超过 3 小时。此外,30%的大血管闭塞患者最初未被诊断,其中一半患者有相应的血栓切除术临床指征:结论:在交通距离血栓切除中心较远的一个县,有很大一部分符合条件的患者没有接受血栓切除术,这对临床结果产生了负面影响。运输时间相当长。最初未确诊的大血管闭塞率很高。
{"title":"Barriers to stroke treatment: The price of long-distance from thrombectomy centers.","authors":"Olav Søvik, Halvor Øygarden, Arnstein Tveiten, Martin Wilhelm Kurz, Kathinka Dæhli Kurz, Pål Johan Stokkeland, Hanne Brit Hetland, Hege Langli Ersdal, Per Kristian Hyldmo","doi":"10.1177/15910199241278036","DOIUrl":"10.1177/15910199241278036","url":null,"abstract":"<p><strong>Background: </strong>Endovascular thrombectomy, the preferred treatment for acute large-vessel occlusion stroke, is highly time-dependent. Many patients live far from thrombectomy centers due to large geographical variations in stroke services. This study aimed to explore the consequences of long transport distance on the proportion of thrombectomy-eligible patients who underwent thrombectomy, the clinical outcomes with or without thrombectomy, the timelines for patients transported, and the diagnostic accuracy of large-vessel occlusion in primary stroke centers.</p><p><strong>Methods: </strong>We conducted a retrospective observational study in a county with only primary stroke centers, ∼ 300 km from the nearest thrombectomy center. All stroke patients admitted over a year were retrieved from the Norwegian Stroke Registry. A neuroradiologist identified all computed tomography images with large-vessel occlusions. A panel determined whether these patients had a corresponding clinical indication for thrombectomy.</p><p><strong>Results: </strong>A total of 50% of the eligible patients did not receive thrombectomy. These patients had a significantly higher risk of severe disability or death compared to the patients who underwent thrombectomy. The median time from computed tomography imaging at the primary stroke center to arrival at the thrombectomy center was over 3 hours. Additionally, 30% of the large-vessel occlusions were initially undiagnosed, and half of these patients had a corresponding clinical indication for thrombectomy.</p><p><strong>Conclusions: </strong>In a county with a long transport distance to a thrombectomy center, a high proportion of eligible patients did not undergo thrombectomy, negatively impacting clinical outcomes. The transport time was considerable. A high rate of large-vessel occlusions was initially not diagnosed.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241278036"},"PeriodicalIF":1.5,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring arteriovenous malformations patient sentiments through 1401 social media posts. 通过 1401 篇社交媒体帖子探究动静脉畸形患者的情绪。
IF 1.5 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-09-05 DOI: 10.1177/15910199241272621
Avi A Gajjar, Georgios S Sioutas, Antonio Corral-Tarbay, Mohamed M Salem, Saarang Patel, Visish M Srinivasan, Brian T Jankowitz, Jan-Karl Burkhardt

Introduction: Social media has allowed patients with rare diseases to connect and discuss their experiences with others online. This study analyzed various social media platforms to better understand the patient's perception of arteriovenous malformation.

Methods: Twitter, Instagram, and TikTok were searched to find posts about patients' experiences with arteriovenous malformations (AVM). Posts unrelated to the patient's experience were excluded. Posts were coded for the relevant themes related to their experience with the disease, as well as engagement, and gender.

Results: The most common theme was raising awareness about the condition (87.0%). Recounting symptoms (50.2%), spreading positivity (17.5%), and survival (8.3%) were other common themes. Other prevalent themes were pain (5.2%) and fear of a rare disease (3.5%). Approximately half of AVM-related Instagram (47.93%) and TikTok (52.94%) posts raised awareness about the condition. Most Instagram (67.75%) and TikTok (89.71%) posts focused on recovery and rehabilitation. Most TikTok posts discussed "survival" or "death" (57.35%), while the majority focused on spreading positivity (79.41%). Most posts were made by women (69.6%). Females were more likely than males to post about the scientific explanation of AVMs (p = 0.003).

Conclusion: Social media allows patients across the country and the globe to discuss their experiences with uncommon diseases and connect with others. It also allows AVM patients to share their experiences with other patients and the public.

简介社交媒体使罕见病患者能够在网上与他人联系并讨论他们的经历。本研究分析了各种社交媒体平台,以更好地了解患者对动静脉畸形的看法:方法:搜索 Twitter、Instagram 和 TikTok,查找有关动静脉畸形 (AVM) 患者经历的帖子。与患者经历无关的帖子被排除在外。对帖子中与患者患病经历相关的主题、参与度和性别进行了编码:最常见的主题是提高对疾病的认识(87.0%)。叙述症状(50.2%)、传播积极的信息(17.5%)和生存(8.3%)是其他常见主题。其他常见主题包括疼痛(5.2%)和对罕见疾病的恐惧(3.5%)。约有一半与 AVM 相关的 Instagram(47.93%)和 TikTok(52.94%)帖子提高了人们对该疾病的认识。大多数 Instagram(67.75%)和 TikTok(89.71%)帖子的重点是恢复和康复。大多数 TikTok 帖子讨论了 "生存 "或 "死亡"(57.35%),而大多数帖子则侧重于传播积极的信息(79.41%)。大多数帖子由女性发布(69.6%)。女性比男性更有可能发布关于反车辆地雷科学解释的帖子(P = 0.003):结论:社交媒体使全国乃至全球的患者能够讨论他们患罕见疾病的经历,并与他人建立联系。它还允许 AVM 患者与其他患者和公众分享他们的经历。
{"title":"Exploring arteriovenous malformations patient sentiments through 1401 social media posts.","authors":"Avi A Gajjar, Georgios S Sioutas, Antonio Corral-Tarbay, Mohamed M Salem, Saarang Patel, Visish M Srinivasan, Brian T Jankowitz, Jan-Karl Burkhardt","doi":"10.1177/15910199241272621","DOIUrl":"10.1177/15910199241272621","url":null,"abstract":"<p><strong>Introduction: </strong>Social media has allowed patients with rare diseases to connect and discuss their experiences with others online. This study analyzed various social media platforms to better understand the patient's perception of arteriovenous malformation.</p><p><strong>Methods: </strong>Twitter, Instagram, and TikTok were searched to find posts about patients' experiences with arteriovenous malformations (AVM). Posts unrelated to the patient's experience were excluded. Posts were coded for the relevant themes related to their experience with the disease, as well as engagement, and gender.</p><p><strong>Results: </strong>The most common theme was raising awareness about the condition (87.0%). Recounting symptoms (50.2%), spreading positivity (17.5%), and survival (8.3%) were other common themes. Other prevalent themes were pain (5.2%) and fear of a rare disease (3.5%). Approximately half of AVM-related Instagram (47.93%) and TikTok (52.94%) posts raised awareness about the condition. Most Instagram (67.75%) and TikTok (89.71%) posts focused on recovery and rehabilitation. Most TikTok posts discussed \"survival\" or \"death\" (57.35%), while the majority focused on spreading positivity (79.41%). Most posts were made by women (69.6%). Females were more likely than males to post about the scientific explanation of AVMs (<i>p</i> = 0.003).</p><p><strong>Conclusion: </strong>Social media allows patients across the country and the globe to discuss their experiences with uncommon diseases and connect with others. It also allows AVM patients to share their experiences with other patients and the public.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241272621"},"PeriodicalIF":1.5,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571157/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142141567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare neurovascular variants that you probably have not seen before. 您可能从未见过的罕见神经血管变异。
IF 1.5 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-08-28 DOI: 10.1177/15910199241272718
Mohamad Abdalkader, Samuel Z Hanz, Eytan Raz, Marialuisa Zedde, Wei Hu, Rosario Pascarella, Zhongming Qiu, Raghid Kikano, Thanh N Nguyen

Background: Recognition of neurovascular variants is crucial for safe endovascular and neurosurgical interventions. We aim to review and highlight various uncommon neurovascular variants and anomalies with a discussion of their relevant embryology and pathology.

Methods: A retrospective review of a prospectively maintained neurovascular database was performed to identify uncommon neurovascular variants and anomalies. A pictorial review of these neurovascular findings is provided along with relevant embryological development, clinical significance, and potential pathological associations.

Results: A pictorial review of selected neurovascular variants and anomalies is presented. These entities, divided between intra- and extra-cranial findings, include infra-optic origin of the anterior cerebral artery, meningo-ophtalmic artery, duplicated posterior cerebral artery, duplicate middle cerebral artery (MCA), MCA fenestration, twig-like MCA, pure arterial malformation, corkscrew basilar artery, persistent hypoglossal artery, persistent trigeminal artery and its variants, direct branches from the common carotid and cervical internal carotid arteries (ICA) (ascending pharyngeal artery from the ICA, thyroidal arteries from the CCA/brachiocephalic, arteria thyroidea ima), and extra-cranial carotid fenestration. The angiographic findings of these entities are presented with relevant 3D reconstruction and multimodal cross-sectional imaging correlation when available.

Conclusions: This pictorial review highlights uncommon neurovascular variants and anomalies that neuroradiologists, interventionalists, and neurosurgeons should be aware of for accurate diagnosis and safe interventions.

背景:识别神经血管变异对于安全的血管内介入和神经外科介入至关重要。我们旨在回顾和强调各种不常见的神经血管变异和异常,并讨论其相关的胚胎学和病理学:方法:我们对前瞻性维护的神经血管数据库进行了回顾性审查,以确定不常见的神经血管变异和异常。方法:对前瞻性维护的神经血管数据库进行回顾性审查,找出不常见的神经血管变异和异常,并对这些神经血管发现以及相关的胚胎发育、临床意义和潜在的病理关联进行图解回顾:结果:图解回顾了部分神经血管变异和异常。这些实体分为颅内和颅外发现,包括大脑前动脉的视窗下起源、脑膜脑动脉、重复的大脑后动脉、重复的大脑中动脉(MCA)、MCA 裂孔、树枝状 MCA、纯动脉畸形、开瓶器基底动脉、持续性舌下动脉、持续性三叉神经动脉及其变体、颈总动脉和颈内动脉(ICA)的直接分支(来自 ICA 的咽上升动脉、来自 CCA/brachiocephalic 的甲状腺动脉、甲状腺 ima 动脉)以及颅外颈动脉瘘。这些实体的血管造影结果与相关的三维重建和多模态横断面成像相关(如有):本图解综述重点介绍了神经放射医师、介入医师和神经外科医师应注意的不常见的神经血管变异和异常,以便准确诊断和安全介入。
{"title":"Rare neurovascular variants that you probably have not seen before.","authors":"Mohamad Abdalkader, Samuel Z Hanz, Eytan Raz, Marialuisa Zedde, Wei Hu, Rosario Pascarella, Zhongming Qiu, Raghid Kikano, Thanh N Nguyen","doi":"10.1177/15910199241272718","DOIUrl":"10.1177/15910199241272718","url":null,"abstract":"<p><strong>Background: </strong>Recognition of neurovascular variants is crucial for safe endovascular and neurosurgical interventions. We aim to review and highlight various uncommon neurovascular variants and anomalies with a discussion of their relevant embryology and pathology.</p><p><strong>Methods: </strong>A retrospective review of a prospectively maintained neurovascular database was performed to identify uncommon neurovascular variants and anomalies. A pictorial review of these neurovascular findings is provided along with relevant embryological development, clinical significance, and potential pathological associations.</p><p><strong>Results: </strong>A pictorial review of selected neurovascular variants and anomalies is presented. These entities, divided between intra- and extra-cranial findings, include infra-optic origin of the anterior cerebral artery, meningo-ophtalmic artery, duplicated posterior cerebral artery, duplicate middle cerebral artery (MCA), MCA fenestration, twig-like MCA, pure arterial malformation, corkscrew basilar artery, persistent hypoglossal artery, persistent trigeminal artery and its variants, direct branches from the common carotid and cervical internal carotid arteries (ICA) (ascending pharyngeal artery from the ICA, thyroidal arteries from the CCA/brachiocephalic, arteria thyroidea ima), and extra-cranial carotid fenestration. The angiographic findings of these entities are presented with relevant 3D reconstruction and multimodal cross-sectional imaging correlation when available.</p><p><strong>Conclusions: </strong>This pictorial review highlights uncommon neurovascular variants and anomalies that neuroradiologists, interventionalists, and neurosurgeons should be aware of for accurate diagnosis and safe interventions.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241272718"},"PeriodicalIF":1.5,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569770/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142082404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep venous outflow as a surrogate for collaterals in late-window patients with successful revascularization from the DEFUSE 3 cohort. DEFUSE 3 队列中血管再通成功的晚窗口期患者的深静脉外流作为袢的替代物。
IF 1.5 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-08-28 DOI: 10.1177/15910199241276905
Gautam Adusumilli, Tobias D Faizy, Soren Christensen, Michael Mlynash, Yince Loh, Gregory W Albers, Maarten G Lansberg, Jens Fiehler, Jeremy J Heit

Background: Deep venous outflow (VO) may be an important surrogate marker of collateral blood flow in acute ischemic stroke patients with a large vessel occlusion (AIS-LVO). Researchers have yet to determine the relationship between deep VO status in late-window patients and imaging measures of collaterals, which are key in preserving tissue.

Materials and methods: We performed a multicenter retrospective cohort study on a subset of DEFUSE 3 patients recruited across 38 centers between May 2016 and May 2017 who underwent successful thrombectomy revascularization. Internal cerebral vein opacification was scored on a scale of 0-2. This metric was added to the cortical vein opacification score to derive the comprehensive VO (CVO) score from 0 to 8. Patients were stratified by favorable (ICV+) and unfavorable (ICV-) ICV scores, and similarly CVO+ and CVO-. Analyses comparing outcomes were primarily conducted by Mann-Whitney U and χ2 tests.

Results: Forty-five patients from DEFUSE 3 were scored and dichotomized into CVO+, CVO-, ICV+, and ICV- categories, with comparable demographics. Hypoperfusion intensity ratio, a marker of tissue level collaterals, was significantly worse in the ICV- and CVO- groups (p = 0.005). ICV- alone was also associated with a larger perfusion lesion (138 ml vs 87 ml; p = 0.023). No significant differences were noted in functional and safety outcomes.

Conclusions: Impaired deep venous drainage alone may be a marker of poor tissue level collaterals and a greater degree of affected tissue in AIS-LVO patients presenting in the late-window who subsequently undergo successful revascularization.

背景:深静脉外流(VO)可能是大血管闭塞(AIS-LVO)急性缺血性卒中患者侧支血流的重要替代指标。研究人员尚未确定晚期窗患者深部 VO 状态与影像学测量侧支之间的关系,而侧支是保护组织的关键:我们对 2016 年 5 月至 2017 年 5 月期间在 38 个中心招募的 DEFUSE 3 患者子集进行了多中心回顾性队列研究,这些患者接受了成功的血栓切除血管重建术。大脑内静脉不透明按 0-2 级评分。该指标与皮质静脉不透明评分相加,得出 0 至 8 分的综合 VO(CVO)评分。根据有利(ICV+)和不利(ICV-)ICV 评分以及类似的 CVO+ 和 CVO- 对患者进行分层。比较结果的分析主要采用 Mann-Whitney U 和 χ2 检验:对 DEFUSE 3 的 45 名患者进行了评分,并将其分为 CVO+、CVO-、ICV+ 和 ICV- 四类,其人口统计学特征具有可比性。低灌注强度比值是组织水平袢的标志,在 ICV- 组和 CVO- 组中明显降低(p = 0.005)。单纯 ICV- 组的灌注病灶也更大(138 毫升 vs 87 毫升;p = 0.023)。在功能和安全性结果方面没有发现明显差异:结论:深静脉引流功能受损可能是组织水平旁路较差的标志,也可能是晚窗口期 AIS-LVO 患者受影响组织较多的标志,这些患者随后成功接受了血管再通手术。
{"title":"Deep venous outflow as a surrogate for collaterals in late-window patients with successful revascularization from the DEFUSE 3 cohort.","authors":"Gautam Adusumilli, Tobias D Faizy, Soren Christensen, Michael Mlynash, Yince Loh, Gregory W Albers, Maarten G Lansberg, Jens Fiehler, Jeremy J Heit","doi":"10.1177/15910199241276905","DOIUrl":"10.1177/15910199241276905","url":null,"abstract":"<p><strong>Background: </strong>Deep venous outflow (VO) may be an important surrogate marker of collateral blood flow in acute ischemic stroke patients with a large vessel occlusion (AIS-LVO). Researchers have yet to determine the relationship between deep VO status in late-window patients and imaging measures of collaterals, which are key in preserving tissue.</p><p><strong>Materials and methods: </strong>We performed a multicenter retrospective cohort study on a subset of DEFUSE 3 patients recruited across 38 centers between May 2016 and May 2017 who underwent successful thrombectomy revascularization. Internal cerebral vein opacification was scored on a scale of 0-2. This metric was added to the cortical vein opacification score to derive the comprehensive VO (CVO) score from 0 to 8. Patients were stratified by favorable (ICV+) and unfavorable (ICV-) ICV scores, and similarly CVO+ and CVO-. Analyses comparing outcomes were primarily conducted by Mann-Whitney <i>U</i> and χ<sup>2</sup> tests.</p><p><strong>Results: </strong>Forty-five patients from DEFUSE 3 were scored and dichotomized into CVO+, CVO-, ICV+, and ICV- categories, with comparable demographics. Hypoperfusion intensity ratio, a marker of tissue level collaterals, was significantly worse in the ICV- and CVO- groups (p = 0.005). ICV- alone was also associated with a larger perfusion lesion (138 ml vs 87 ml; p = 0.023). No significant differences were noted in functional and safety outcomes.</p><p><strong>Conclusions: </strong>Impaired deep venous drainage alone may be a marker of poor tissue level collaterals and a greater degree of affected tissue in AIS-LVO patients presenting in the late-window who subsequently undergo successful revascularization.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"15910199241276905"},"PeriodicalIF":1.5,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142082380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Interventional Neuroradiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1